U.S. authorities have charged two executives of CANARX, a Canadian pharmaceutical company, with operating a scheme to illegally import prescription drugs into the United States. On Sunday, John Thomas Howard, the company’s treasurer and director, was arrested on charges including smuggling and conspiracy. His brother, Bob Howard, serving as president and another director, is wanted but remains at large.
Court documents indicate that John Thomas Howard faced multiple charges, including the introduction of misbranded drugs into interstate commerce. The investigation conducted by the Food and Drug Administration (FDA) revealed that CANARX may have imported prescription drugs unlawfully. While specific medications linked to the allegations were not detailed, the investigation period spans from February 2017 to April 2026.
CANARX, established in 2002 in Windsor, Ontario, promotes itself as a safe international prescription provider, sourcing drugs from countries like Canada, the UK, Australia, and New Zealand. However, the FDA and other federal officials have raised concerns regarding the legality and safety of these practices. A 2022 CNBC investigation noted that alternative funding programs (AFPs), which often facilitate the importation of high-cost specialty drugs, have become prevalent as U.S. drug prices increase.
In prior actions, the FDA has confiscated medications from CANARX identified as potentially misbranded and issued warnings regarding the company’s operations, which the firm contended were legal. Meanwhile, Gilead Sciences is pursuing a civil lawsuit against CANARX and others for the illegal importation of its HIV treatment drug, Biktarvy.
Why this story matters: The case raises critical questions about drug importation legality and patient safety.
Key takeaway: The arrest of CANARX officials highlights ongoing regulatory scrutiny of alternative drug sourcing models in the U.S.
Opposing viewpoint: CANARX maintains that its operations are lawful and argue that imported medications from highly regulated countries are safe for patients.
